Translating Research Into Practice
Guideline Evaluation
Diane Wardell, PhD, RN, WHNP-BC, AHN-BC
From University of Texas Health Science Center–School of Nursing, Houston, Texas
The author has no conflicts of interest to disclose.
Correspondence to: Diane Wardell, PhD, RN, WHNP-BC, AHN-BC, UTHSC-SON Family Health, 6901 Bertner Avenue, Houston, TX 77030.
E-mail: diane.wardell@uthtmc.edu
J Adv Pract Oncol 2013;4:62–64 |
DOI: 10.6004/jadpro.2013.4.1.8 |
© 2013 Harborside Press®
ABSTRACT
With the advent of the Papanicolaou (Pap) test in 1945, mortality from cervical carcinoma declined more than 70%. An annual Pap smear was the recommended guideline for many years. But new guidelines recently released by the USPSTF recommend far less screening for various subgroups of women. In the first part of this two-part series, read about the implications of the new guidelines. This second part presents a primer for APs to critically evaluate guidelines.
For access to the full length article, please
sign in.
